The objective of this study was to investigate the potential of xenograft (cancellous bovine bone) granules to form vital bone in non-natural bone-forming areas of maxillary sinuses. Fourteen sinus augmentations were performed in 14 patients. Surgical outcomes were uneventful, and sufficient radiopaque volume was present radiographically to place dental implants in all sites. Clinical reentry at 6 months revealed bone formation at the osteotomy site. Histologic evaluation of the obtained bone cores revealed that xenograft granules were integrated and surrounded by woven bone and lamellar bone that were in close contact with the particles. The average percentage of newly formed bone at 6 months was 27.5% ± 8.9%. Vital bone formation using the xenograft granules was supported by both clinical and histologic evidence.

The clinical and histologic efficacy of xenograft granules for maxillary sinus floor augmentation / M. Nevins, M. Camelo, N. De Angelis, J.J. Hanratty, W.G. Khang, J.J. Kwon, G. Rasperini, I. Rocchietta, P. Schupbach, D.M. Kim. - In: THE INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY. - ISSN 0198-7569. - 31:3(2011 Jun), pp. 227-235.

The clinical and histologic efficacy of xenograft granules for maxillary sinus floor augmentation

G. Rasperini;
2011

Abstract

The objective of this study was to investigate the potential of xenograft (cancellous bovine bone) granules to form vital bone in non-natural bone-forming areas of maxillary sinuses. Fourteen sinus augmentations were performed in 14 patients. Surgical outcomes were uneventful, and sufficient radiopaque volume was present radiographically to place dental implants in all sites. Clinical reentry at 6 months revealed bone formation at the osteotomy site. Histologic evaluation of the obtained bone cores revealed that xenograft granules were integrated and surrounded by woven bone and lamellar bone that were in close contact with the particles. The average percentage of newly formed bone at 6 months was 27.5% ± 8.9%. Vital bone formation using the xenograft granules was supported by both clinical and histologic evidence.
Settore MED/28 - Malattie Odontostomatologiche
Settore MED/29 - Chirurgia Maxillofacciale
giu-2011
http://www.quintpub.com/journals/prd/full_txt_pdf_alert.php?article_id=10740&ref=/journals/prd/journal_contents.php?iss_id=9364ZZ5journal_name=PRD4ZZ5vol_year=20114ZZ5vol_num=31
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/193356
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact